GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medrx Co Ltd (TSE:4586) » Definitions » Price-to-Free-Cash-Flow

Medrx Co (TSE:4586) Price-to-Free-Cash-Flow : N/A (As of Jun. 23, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Medrx Co Price-to-Free-Cash-Flow?

As of today (2024-06-23), Medrx Co's share price is 円165.00. Medrx Co's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 was 円0.00. Hence, Medrx Co's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Medrx Co's Price-to-Free-Cash-Flow or its related term are showing as below:

During the past 13 years, Medrx Co's highest Price-to-Free-Cash-Flow Ratio was 11.91. The lowest was 0.00. And the median was 4.67.

TSE:4586's Price-to-Free-Cash-Flow is not ranked *
in the Drug Manufacturers industry.
Industry Median: 22.85
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Medrx Co's Free Cash Flow per Share for the three months ended in Mar. 2024 was 円0.00. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was 円0.00.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was 25.30% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 29.40% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was 14.70% per year.

During the past 13 years, Medrx Co's highest 3-Year average Free Cash Flow per Share Growth Rate was 34.30% per year. The lowest was -10.70% per year. And the median was 12.35% per year.


Medrx Co Price-to-Free-Cash-Flow Historical Data

The historical data trend for Medrx Co's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medrx Co Price-to-Free-Cash-Flow Chart

Medrx Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Medrx Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Medrx Co's Price-to-Free-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Medrx Co's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medrx Co's Price-to-Free-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medrx Co's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Medrx Co's Price-to-Free-Cash-Flow falls into.



Medrx Co Price-to-Free-Cash-Flow Calculation

Medrx Co's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=165.00/0
=N/A

Medrx Co's Share Price of today is 円165.00.
Medrx Co's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Medrx Co  (TSE:4586) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Medrx Co Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Medrx Co's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Medrx Co (TSE:4586) Business Description

Traded in Other Exchanges
N/A
Address
431-7 Nishiyama, Higashikagawa, Kagawa, JPN, 769-2712
Medrx Co Ltd is a pharmaceutical drug development company founded in January, 2002. The Company engaged in the research and development of pharmaceutical products utilizing the pharmaceutical formulation technology based on ionic liquid transdermal system. The Company develops new pharmaceutical candidates and licenses other companies to produce the pharmaceuticals after clinical trials. Its main products include analgesic patches for anti-inflammatory and pain relief.

Medrx Co (TSE:4586) Headlines

No Headlines